# Correction to: The CEPH aging cohort and biobank: a valuable collection of biological samples from exceptionally long-lived French individuals and their offspring for longevity studies

Alexandre How-Kit, Mourad Sahbatou, Lise Hardy, Nicolas Tessier, Valérie Schiavon, Hélène Le Buanec, Jean-Marc Sebaoun, Hélène Blanché, Jean-François Zagury, Jean-françois Deleuze

► To cite this version:

Alexandre How-Kit, Mourad Sahbatou, Lise Hardy, Nicolas Tessier, Valérie Schiavon, et al. Correction to: The CEPH aging cohort and biobank: a valuable collection of biological samples from exceptionally long-lived French individuals and their offspring for longevity studies. GeroScience, 2024, 46 (3), pp.3503-3505. 10.1007/s11357-024-01085-4. hal-05313985

HAL Id: hal-05313985

https://hal.science/hal-05313985v1

Submitted on 14 Oct 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# Correction to: The CEPH aging cohort and biobank: a valuable collection of biological samples from exceptionally long-lived French individuals and their offspring for longevity studies

Alexandre How-Kit · Mourad Sahbatou · Lise M. Hardy · Nicolas P. Tessier · Valérie Schiavon · Hélène Le Buanec · Jean-Marc Sebaoun · Hélène Blanché · Jean-François Zagury · Jean-François Deleuze

Published online: 26 January 2024
© The Author(s) 2024

Correction to: GeroScience
https://doi.org/10.1007/s11357-023-01037-4

The original version of this article contained a few errors introduced during the typesetting process.

There were errors in the brackets used to delimit age intervals in the abstract and Table 2. We have corrected the age intervals to avoid any confusion.

"semi-supercentenarians ([105–110] years old)" has been corrected to "semi-supercentenarians ([105–109] years old)" in the Abstract.

"[90–100]; nonagenarians", "[100–105]", and "[105–110]; semi-supercentenarians" have been

<footnote>The original article can be found online at https://doi.org/10.1007/s11357-023-01037-4.</footnote>

<footnote>A. How-Kit (✉) · M. Sahbatou · L. M. Hardy · N. P. Tessier · J.-F. Deleuze (✉)
Laboratory for Genomics, Foundation Jean Dausset - CEPH, Paris, France
e-mail: alexandre.how-kit@fjd-ceph.org</footnote>

<footnote>J.-F. Deleuze
e-mail: deleuze@cnrgh.fr</footnote>

<footnote>A. How-Kit · L. M. Hardy · N. P. Tessier · H. Blanché · J.-F. Deleuze
Laboratory of Excellence GenMed, Paris, France</footnote>

<footnote>V. Schiavon · H. Le Buanec
INSERM U976 - HIPI Unit, Saint-Louis Research Institute, University of Paris, Paris, France</footnote>

<footnote>J.-M. Sebaoun · H. Blanché · J.-F. Deleuze
Centre de Ressources Biologiques, Foundation Jean Dausset - CEPH, Paris, France</footnote>

<footnote>J.-F. Zagury
Équipe Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Conservatoire National Des Arts et Métiers, HESAM Université, Paris, France</footnote>

<footnote>J.-F. Deleuze
Centre National de Recherche en Génomique Humaine, CEA, Institut François Jacob, Evry, France</footnote>
corrected to “[90–99]; nonagenarians”, “[100–104]”, and “[105–109]; semi-supercentenarians” in Table 2, respectively.

New Table 2:

<table><caption>**Table 2** Demographic characteristics of the long-lived individuals from the CEPH Aging cohort</caption><thead><tr><th rowspan="2">Age range (years)</th><th colspan="2">Participants (N) considering their age at inclusion</th><th colspan="2">Participants (N) considering their age at death</th><th colspan="2">Participants (N) considering their age at last known health status</th></tr><tr><th>All (% of women)</th><th>Unrelated</th><th>All (% of women)</th><th>Unrelated</th><th>All (% of women)</th><th>Unrelated</th></tr></thead><tbody><tr><td>≥90</td><td>1712 (75.76)</td><td>1411</td><td>1454 (76.96)</td><td>1207</td><td>1746 (75.43)</td><td>1412</td></tr><tr><td>[90-99]; nonagenarians</td><td>710 (63.10)</td><td>487</td><td>347 (54.47)</td><td>234</td><td>481 (54.68)</td><td>321</td></tr><tr><td>≥100; centenarians</td><td>1002 (84.73)</td><td>996</td><td>1107 (84.01)</td><td>1063</td><td>1265 (83.32)</td><td>1212</td></tr><tr><td>[100-104]</td><td>930 (84.62)</td><td>927</td><td>874 (82.49)</td><td>841</td><td>984 (82.22)</td><td>944</td></tr><tr><td>[105-109]; semi-supercentenarians</td><td>66 (84.85)</td><td>66</td><td>218 (90.37)</td><td>218</td><td>256 (87.89)</td><td>255</td></tr><tr><td>≥110; supercentenarians</td><td>6 (100)</td><td>6</td><td>15 (80)</td><td>15</td><td>25 (80)</td><td>25</td></tr></tbody></table>

Table 3 was incorrectly justified and had a typo, which has been corrected.

New Table 3:

<table><caption>**Table 3** Quantitative epidemiologic and clinical data available for long-lived individuals from the CEPH Aging cohort</caption><thead><tr><th rowspan="2"></th><th colspan="2">All</th><th colspan="2">Men</th><th colspan="2">Women</th></tr><tr><th>% of data available</th><th>Mean ± SD</th><th>% of data available</th><th>Mean ± SD</th><th>% of data available</th><th>Mean ± SD</th></tr></thead><tbody><tr><td><strong>Anthropometry</strong></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Age at inclusion (years)</td><td>100</td><td>98.9 ± 4.17</td><td>100</td><td>96.6 ± 4.57</td><td>100</td><td>99.64 ± 3.73</td></tr><tr><td>Height (cm)</td><td>55.78</td><td>160.06 ± 8.65</td><td>61.77</td><td>167.94 ± 7.1</td><td>53.83</td><td>157.11 ± 7.21</td></tr><tr><td>Weight (kg)</td><td>58.07</td><td>54.98 ± 12.75</td><td>62.23</td><td>65.84 ± 10.68</td><td>56.71</td><td>51.09 ± 11.08</td></tr><tr><td><strong>Cardiovascular parameters</strong></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pulse rate (bpm)</td><td>49.94</td><td>74.23 ± 8.88</td><td>50.34</td><td>71.5 ± 8.61</td><td>49.81</td><td>75.13 ± 8.79</td></tr><tr><td>Systolic blood pressure (cm Hg)</td><td>58.93</td><td>13.65 ± 1.6</td><td>58.74</td><td>13.57 ± 1.45</td><td>58.99</td><td>13.67 ± 1.64</td></tr><tr><td>Diastolic blood pressure (cm Hg)</td><td>58.19</td><td>7.63 ± 0.87</td><td>58.04</td><td>7.66 ± 0.79</td><td>58.23</td><td>7.62 ± 0.89</td></tr><tr><td><strong>Blood test</strong></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total cholesterol (g/L)</td><td>13.11</td><td>2.07 ± 0.55</td><td>13.75</td><td>2 ± 0.71</td><td>12.9</td><td>2.1 ± 0.49</td></tr><tr><td>LDL cholesterol (g/L)</td><td>4.41</td><td>1.21 ± 0.41</td><td>3.72</td><td>1.1 ± 0.43</td><td>4.63</td><td>1.23 ± 0.4</td></tr><tr><td>HDL cholesterol (g/L)</td><td>5.09</td><td>0.52 ± 0.19</td><td>3.96</td><td>0.52 ± 0.28</td><td>5.46</td><td>0.52 ± 0.16</td></tr><tr><td>Blood glucose (g/L)</td><td>30.18</td><td>1 ± 0.56</td><td>31.7</td><td>1.07 ± 0.64</td><td>29.68</td><td>0.97 ± 0.53</td></tr><tr><td>Urea (g/L)</td><td>20.84</td><td>0.49 ± 0.25</td><td>20.74</td><td>0.5 ± 0.18</td><td>20.88</td><td>0.49 ± 0.27</td></tr><tr><td>Creatinine level (mg/L)</td><td>33.56</td><td>11.06 ± 3.82</td><td>37.06</td><td>12.5 ± 3.94</td><td>32.42</td><td>10.53 ± 3.64</td></tr><tr><td><strong>Cognitive function</strong></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Folstein test (points)</td><td>20.84</td><td>19.62 ± 7.46</td><td>22.14</td><td>22 ± 6.23</td><td>20.42</td><td>18.78 ± 7.69</td></tr><tr><td>SPMSQ (points)</td><td>49.26</td><td>6.22 ± 3.57</td><td>51.28</td><td>7.62 ± 3.54</td><td>48.60</td><td>5.77 ± 3.47</td></tr></tbody></table>
We have also corrected gene names that were not ital-
icized in the Discussion.

"It allowed the identification of APOE (p<0.001) and ACE (p<0.01) as the first genes associated with human longevity in 1994 using a candidate gene approach in a case-control study including 338 centenarians and 410 adults aged 20-70 years [22]. However, while APOE association was largely replicated in many other studies [23, 24], ACE association should be considered as a false positive signal due to genotyping issues [32]." was corrected to "It allowed the identification of APOE (p<0.001) and ACE (p<0.01) as the first genes associated with human longevity in 1994 using a candidate gene approach in a case-control study including 338 centenarians and 410 adults aged 20-70 years [22]. However, while APOE association was largely replicated in many other studies

[23, 24], ACE association should be considered as a
false positive signal due to genotyping issues [32]."

**Open Access** This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

**Publisher's Note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.